Stem cell gene therapy - search results

Prof Colin J Suckling OBE DSc FRSE from the Department of Pure & Applied Chemistry, details the ‘why’ and ‘what’ of academic drug discovery research at the University of Strathclyde, as well as his thoughts on the value of a chemistry degree.

Stephen C Clark, from Newcastle upon Tyne Hospitals NHS Foundation Trust and University of Northumbria in the UK explains idiopathic pulmonary fibrosis, a type of lung disease.

Dr Shiksha Gallow, Medical Director of Biodata and Head Researcher at Cannabis Oil Research, provides evidence-based research on cannabinoids for treating MS and Prostate Cancer.

Today, people use cannabis products such as CBD for numerous medicinal benefits, here we find out how it can help in treating anxiety.

Prof Filippo Graziani, President of the European Federation of Periodontology (EFP), turns the spotlight on periodontitis and answers if gum disease increases the risk of hypertension, heart attack and stroke.

Gregory H Hipskind MD PhD and Jody L Mittiga DNM NP from Brain Injury Consulting LLC, reveal their thoughts on evaluating and treating mild traumatic brain injury (mTBI), including the role of SPECT and photobiomodulation therapy.

Michael Roth, Research Group Leader at University Hospital Basel asks if fine dust air pollution (PM2.5) is a cause of chronic inflammatory lung diseases and provides a most engaging response.

However, the majority of clinical standards for diagnosis and treatment in modern oncology are traditionally birthed solely from biological investigations.

In this exclusive interview with Prof Olufunmilayo Lesi, Regional Medical Officer for Viral Hepatitis from the World Health Organization (WHO) Office for the Africa Region, discusses tackling viral hepatitis in Africa.

In this detailed analysis, Jérôme Galon and Daniela Bruni at INSERM, Laboratory of Integrative Cancer Immunology, Centre de Recherche des Cordeliers, in France, discuss colorectal cancer.

Using cross-disciplinary technology, Dr Kunio Matsumoto, PhD, Professor at Kanazawa University in Japan is extending research on growth factor toward synthetic biologics for regeneration-based medicine and cancer theranostics.

GreenLight Medicines is a supplier of quality supplements and is an active MedCan research company GreenLight, Supplements and Medicines.

Regina Fluhrer from the University of Augsburg and Bernd Schröder from the TU in Dresden discuss the potential of intramembrane proteases as targets for cancer therapies.

Transcending morphology, magnetic resonance techniques can be utilised to shed light on processes on the molecular level to unveil pathological alterations preceding anatomical and functional manifestations of (cardiovascular) diseases, in the view of Ulrich Flögel from Heinrich Heine University Düsseldorf, Germany.

A new £2.6 million project led by Swansea University Medical School aims to dramatically improve the diagnosis and treatment of ovarian cancer.

Dr Elizabeth Robertson, Director of Research at Diabetes UK explains why 2019 marked turning a corner in the prevention of Type 1 diabetes but adds that there is still more research to be done in this area.

John Greenwood PhD FRCPath and Stephen E. Moss PhD from UCL Institute of Ophthalmology discuss the vasculature in health and disease, a major focus of their research.

Lalit P. Singh, Associate Professor at Wayne State University School of Medicine, explains the role of TXNIP in mitochondrial-lysosomal axis dysregulation in diabetic retinopathy.

Dr Gerry Morrow shares his thoughts on the precision medicine, defined as the cost-effectiveness of breakthrough treatments and explains why this area is a priority for both researchers and government.

Patients will benefit from significant government investment in new NHS technology to improve treatment, diagnosis and care options for diseases including cancer.